Cart
sales@molnova.com
G007-LK
CAS No. 1380672-07-0
G007-LK ( G007LK; G007LK; G007 LK )
Catalog No. M17270 CAS No. 1380672-07-0
G007-LK is a selective inhibitor of TNKS1 and TNKS2, with IC50s of 46 nM and 25 nM, respectively.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 58 | In Stock |
|
| 5MG | 90 | In Stock |
|
| 10MG | 152 | In Stock |
|
| 25MG | 316 | In Stock |
|
| 50MG | 502 | In Stock |
|
| 100MG | 707 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameG007-LK
-
NoteResearch use only, not for human use.
-
Brief DescriptionG007-LK is a selective inhibitor of TNKS1 and TNKS2, with IC50s of 46 nM and 25 nM, respectively.
-
DescriptionG007-LK is a potent, "rule of 5" compliant and a metabolically stable TNKS1/2 inhibitor. G007-LK displayed high selectivity toward tankyrases 1 and 2 with biochemical IC50 values of 46 nM and 25 nM, respectively, and a cellular IC50 value of 50 nM combined with an excellent pharmacokinetic profile in mice. G007-LK was first discovered by Dr. Stefan Krauss's team.
-
SynonymsG007LK; G007LK; G007 LK
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorTNKS1;TNKS2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1380672-07-0
-
Formula Weight529.96
-
Molecular FormulaC25H16ClN7O3S
-
Purity98%
-
SolubilityDMSO : ≥ 30 mg/mL. 56.61 mM
-
SMILESCS(=O)(=O)c1cnc(cc1)c1nnc(n1c1ccccc1Cl)/C=C/c1nnc(o1)c1ccc(cc1)C#N
-
Chemical Name(E)-4-(5-(2-(4-(2-chlorophenyl)-5-(5-(methylsulfonyl)pyridin-2-yl)-4H-1,2,4-triazol-3-yl)vinyl)-1,3,4-oxadiazol-2-yl)benzonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Voronkov A,etal.Structural basis and SAR for G007-LK, a lead stage 1,2,4-triazole based specific tankyrase 1/2 inhibitor.J Med Chem. 2013 Apr 11;56(7):3012-23.
molnova catalog
related products
-
Bethanechol chloride
Bethanechol chloride is a selective muscarinic receptor agonist without any effect on nicotinic receptors.
-
Scopolamine HBr
Scopolamine hydrobromide is a competitive muscarinic acetylcholine receptor (mAChR) with an IC50 of 55.3 ± 4.3 nM.
-
Hodostin
Neostigmine methyl sulfate is a cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
